Table 5 Logistic regression analysis of risk factors for recurrence of CIP.

From: The application of bronchoscopy in the assessment of immune checkpoint inhibitor-related pneumonitis severity and recurrence

Factors

Univariate analysis

OR

95% CI

P

Age

0.942

0.817–1.085

0.404

Sex (male vs. female)

0.571

0.041–8.049

0.678

Smoking status (yes vs. never)

1.818

0.160–20.714

0.630

Thoracic radiotherapy (yes vs.no)

1.167

0.151–9.006

0.882

Pre-ILD (yes vs.no)

2.00

0.241–16.612

0.521

Duration of immunotherapy (< 3 months vs.≧ 3 months)

4.00

0.363–44.113

0.258

PD1 vs. PDL1 inhibitors

1.333

0.113–15.704

0.819

LDH

1.001

0.990–1.012

0.842

hsCRP

0.994

0.970–1.018

0.602

Blood routine test

 Lymphocyte

0.036

0.001–2.056

0.107

 Eosinophil

1.328

0.609–2.896

0.475

 Neutrophil

0.908

0.545–1.514

0.711

NLR

1.149

0.882–1.496

0.303

BALF

 Lymphocyte percentage

1.123

1.005–1.255

0.040

CD4/CD8 ≧1 vs. < 1

16.00

1.093–234.248

0.043

Back to article page